Skip to the page

Data / Form D filings / Kilele Health Inc.

Kilele Health Inc.: Form D filing

Kilele Health Inc., a biotechnology company in Oakwood, OH, filed a Form D with the SEC in 2025. The latest, on October 1, 2025, reports $264,500 sold of a $2 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
201 E. Dixon Ave, Oakwood, OH, 45419
Phone
(317) 850-0442
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b), Securities Act section 4(a)(5)
SEC identifier (CIK)
2087187

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 1, 2025New notice$2,000,000$264,500$1,735,5003Sep 23, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason Charles HeikenfeldExecutive Officer, Director, Promoter
Sven Charles SchreiberExecutive Officer
Andrew David CothrelExecutive Officer, Director, Promoter
Brittany Nicole ArdeExecutive Officer

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Sep 29, 2025 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Kilele Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.